Tesla plans to enter Texas deregulated energy market, starts with massive 250 MW battery

Tesla has filed to enter Texas’s deregulated energy market and become an official electricity retailer. For a change, the company sees an opportunity not to disrupt but to fix and stabilize the market. After winter storms earlier this year, the Texas grid experienced widespread blackouts, leading to more than a hundred deaths and billions in… Continue reading Tesla plans to enter Texas deregulated energy market, starts with massive 250 MW battery

SE Asia tech dealmaking booms as investors place post-COVID bets

Fintech and e-commerce companies in Southeast Asia are raising hefty amounts of capital as global investors bet on post-pandemic technology plays, bankers and investors said, a trend that is also stoking concerns about frothy valuations. Public equity capital raising by Southeast Asian firms has surged to a four-year high of $8.4 billion this year, data from Refinitiv shows, with… Continue reading SE Asia tech dealmaking booms as investors place post-COVID bets

China Digest: HK’s DayDayCook agrees to SPAC merger; Primavera sets up US office

Hong Kong’s DayDayCook will merge with a blank-cheque firm to go public in the US, while Primavera Capital Group has officially established its US office. HK-based DayDayCook heads to Nasdaq via SPAC DayDayCook, a Hong Kong-based online cooking community platform backed by Alibaba, has agreed to merge with a special purpose acquisition company (SPAC) to go… Continue reading China Digest: HK’s DayDayCook agrees to SPAC merger; Primavera sets up US office

China’s Maison Capital closes fifth RMB-denominated fund at $231m

Maison Capital, an investment firm that has backed Chinese drone giant DJI, has closed an oversubscribed, new RMB-denominated fund at about 1.5 billion yuan ($231.4 million), it announced on Thursday. The new fund will help Maison Capital double down on growth-stage enterprises in the fields of healthcare, advanced technology, and consumption upgrade. The fund, Maison… Continue reading China’s Maison Capital closes fifth RMB-denominated fund at $231m

China said to plan ban on US listings of tech firms with data security risks

China is framing rules to ban internet companies whose data poses potential security risks from listing outside the country, including in the United States, according to a person familiar with the matter. The ban is also expected to be imposed on companies involved in ideology issues, said the person, declining to be identified as the… Continue reading China said to plan ban on US listings of tech firms with data security risks

‘Bravely Default II’ is heading to Steam on September 2nd

The main Bravely Default games are famously known for being Nintendo exclusives, and the latest entry in the franchise launched only for the Switch. Pretty soon, though, you’ll be able to play Bravely Default II on a non-Nintendo device: The third main installment in the JRPG series will be available on Steam starting on September… Continue reading ‘Bravely Default II’ is heading to Steam on September 2nd

Indian VC firm A91 Partners secures final close of second fund at $525m: Report

Venture capital firm A91 Partners, floated by former Sequoia Capital executives, has reportedly reached the final close of its second fund by garnering $525 million in capital commitments. The sponsors or limited partners in the fund include the Canada Pension Plan Investment Board and financial services major Allianz group, The Economic Times reported. The firm… Continue reading Indian VC firm A91 Partners secures final close of second fund at $525m: Report

LAV leads $50m Series B funding in Chinese drug maker Link Pharmaceuticals

Clinical stage drug maker Lynk Pharmaceuticals Co. has completed a Series B round of financing, raising as much as $50 million, led by the Shanghai-based venture capital firm Lilly Asia Ventures (LAV), the investor announced on Friday.  New investors New Alliance Capital and Hangzhou Heda Industry Fund participated in the round, while returning investors Legend… Continue reading LAV leads $50m Series B funding in Chinese drug maker Link Pharmaceuticals